Drugs / I-01/23
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07032142 | Jul 2025 → Jul 2028 expected | cancer, chemotherapy-induced toxicity | D'Or Institute for Research and Education | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | I-01/23 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07032142 ↗ |